Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 994

1.

The Extended Impact of Human Immunodeficiency Virus/AIDS Research.

Schwetz TA, Fauci AS.

J Infect Dis. 2018 Aug 28. doi: 10.1093/infdis/jiy441. [Epub ahead of print]

PMID:
30165415
2.

Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7.

Lertjuthaporn S, Cicala C, Van Ryk D, Liu M, Yolitz J, Wei D, Nawaz F, Doyle A, Horowitch B, Park C, Lu S, Lou Y, Wang S, Pan R, Jiang X, Villinger F, Byrareddy SN, Santangelo PJ, Morris L, Wibmer CK, Biris K, Mason RD, Gorman J, Hiatt J, Martinelli E, Roederer M, Fujikawa D, Gorini G, Franchini G, Arakelyan A, Ansari AA, Pattanapanyasat K, Kong XP, Fauci AS, Arthos J.

PLoS Pathog. 2018 Aug 28;14(8):e1007278. doi: 10.1371/journal.ppat.1007278. eCollection 2018 Aug.

3.

Ending the HIV Epidemic in the United States: Closing the Implementation Gaps.

Marston HD, Dieffenbach CW, Fauci AS.

Ann Intern Med. 2018 Aug 21. doi: 10.7326/M18-1944. [Epub ahead of print] No abstract available.

PMID:
30140920
4.

Tickborne Diseases - Confronting a Growing Threat.

Paules CI, Marston HD, Bloom ME, Fauci AS.

N Engl J Med. 2018 Aug 23;379(8):701-703. doi: 10.1056/NEJMp1807870. Epub 2018 Jul 25. No abstract available.

5.

MAdCAM costimulation through Integrin-α4β7 promotes HIV replication.

Nawaz F, Goes LR, Ray JC, Olowojesiku R, Sajani A, Ansari AA, Perrone I, Hiatt J, Van Ryk D, Wei D, Waliszewski M, Soares MA, Jelicic K, Connors M, Migueles SA, Martinelli E, Villinger F, Cicala C, Fauci AS, Arthos J.

Mucosal Immunol. 2018 Jun 6. doi: 10.1038/s41385-018-0044-1. [Epub ahead of print]

PMID:
29875402
6.

US and Cuban Scientists Forge Collaboration on Arbovirus Research.

Pérez-Ávila J, Guzmán-Tirado MG, Fraga-Nodarse J, Handley G, Meegan J, Pelegrino-Martínez de la Cotera JL, Fauci AS.

MEDICC Rev. 2018 Apr;20(2):32-34.

7.

Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases.

Graham BS, Mascola JR, Fauci AS.

JAMA. 2018 Apr 10;319(14):1431-1432. doi: 10.1001/jama.2018.0345. No abstract available.

PMID:
29566112
8.

Monoclonal Antibodies for Emerging Infectious Diseases - Borrowing from History.

Marston HD, Paules CI, Fauci AS.

N Engl J Med. 2018 Apr 19;378(16):1469-1472. doi: 10.1056/NEJMp1802256. Epub 2018 Mar 7. No abstract available.

9.

A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.

Erbelding EJ, Post DJ, Stemmy EJ, Roberts PC, Augustine AD, Ferguson S, Paules CI, Graham BS, Fauci AS.

J Infect Dis. 2018 Jul 2;218(3):347-354. doi: 10.1093/infdis/jiy103.

PMID:
29506129
10.

The Role of Integrin α4β7 in HIV Pathogenesis and Treatment.

Arthos J, Cicala C, Nawaz F, Byrareddy SN, Villinger F, Santangelo PJ, Ansari AA, Fauci AS.

Curr HIV/AIDS Rep. 2018 Apr;15(2):127-135. doi: 10.1007/s11904-018-0382-3. Review.

11.

Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120.

Yolitz J, Schwing C, Chang J, Van Ryk D, Nawaz F, Wei D, Cicala C, Arthos J, Fauci AS.

Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2443-2448. doi: 10.1073/pnas.1722627115. Epub 2018 Feb 20.

12.

Ending the HIV/AIDS Pandemic1.

Eisinger RW, Fauci AS.

Emerg Infect Dis. 2018 Mar;24(3):413-416. doi: 10.3201/eid2403.171797.

13.

Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes.

Sivro A, Schuetz A, Sheward D, Joag V, Yegorov S, Liebenberg LJ, Yende-Zuma N, Stalker A, Mwatelah RS, Selhorst P, Garrett N, Samsunder N, Balgobin A, Nawaz F, Cicala C, Arthos J, Fauci AS, Anzala AO, Kimani J, Bagaya BS, Kiwanuka N, Williamson C, Kaul R, Passmore JS, Phanuphak N, Ananworanich J, Ansari A, Abdool Karim Q, Abdool Karim SS, McKinnon LR; CAPRISA004 and RV254 study groups.

Sci Transl Med. 2018 Jan 24;10(425). pii: eaam6354. doi: 10.1126/scitranslmed.aam6354.

PMID:
29367348
14.

PEPFAR - 15 Years and Counting the Lives Saved.

Fauci AS, Eisinger RW.

N Engl J Med. 2018 Jan 25;378(4):314-316. doi: 10.1056/NEJMp1714773. No abstract available.

15.

Reimagining the Research Approach to Tuberculosis.

Fauci AS, Eisinger RW.

Am J Trop Med Hyg. 2018 Mar;98(3):650-652. doi: 10.4269/ajtmh.17-0999. Epub 2018 Jan 11.

16.

Early treatment of SIV+ macaques with an α4β7 mAb alters virus distribution and preserves CD4+ T cells in later stages of infection.

Santangelo PJ, Cicala C, Byrareddy SN, Ortiz KT, Little D, Lindsay KE, Gumber S, Hong JJ, Jelicic K, Rogers KA, Zurla C, Villinger F, Ansari AA, Fauci AS, Arthos J.

Mucosal Immunol. 2018 May;11(3):932-946. doi: 10.1038/mi.2017.112. Epub 2017 Dec 20.

17.

A Universal Flu Vaccine Is Vital.

Paules CI, Fauci AS.

Sci Am. 2018 Jan 16;318(2):8. doi: 10.1038/scientificamerican0218-8. No abstract available.

PMID:
29337938
18.

Pandemic Zika: A Formidable Challenge to Medicine and Public Health.

Morens DM, Fauci AS.

J Infect Dis. 2017 Dec 16;216(suppl_10):S857-S859. doi: 10.1093/infdis/jix383. No abstract available.

PMID:
29267908
19.

A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection.

Sneller MC, Justement JS, Gittens KR, Petrone ME, Clarridge KE, Proschan MA, Kwan R, Shi V, Blazkova J, Refsland EW, Morris DE, Cohen KW, McElrath MJ, Xu R, Egan MA, Eldridge JH, Benko E, Kovacs C, Moir S, Chun TW, Fauci AS.

Sci Transl Med. 2017 Dec 6;9(419). pii: eaan8848. doi: 10.1126/scitranslmed.aan8848.

PMID:
29212716
20.

Chasing Seasonal Influenza - The Need for a Universal Influenza Vaccine.

Paules CI, Sullivan SG, Subbarao K, Fauci AS.

N Engl J Med. 2018 Jan 4;378(1):7-9. doi: 10.1056/NEJMp1714916. Epub 2017 Nov 29. No abstract available.

21.

What Recent History Has Taught Us About Responding to Emerging Infectious Disease Threats.

Paules CI, Eisinger RW, Marston HD, Fauci AS.

Ann Intern Med. 2017 Dec 5;167(11):805-811. doi: 10.7326/M17-2496. Epub 2017 Nov 14.

PMID:
29132162
22.

An HIV Vaccine Is Essential for Ending the HIV/AIDS Pandemic.

Fauci AS.

JAMA. 2017 Oct 24;318(16):1535-1536. doi: 10.1001/jama.2017.13505. No abstract available.

PMID:
29052689
23.

The Pathway to a Universal Influenza Vaccine.

Paules CI, Marston HD, Eisinger RW, Baltimore D, Fauci AS.

Immunity. 2017 Oct 17;47(4):599-603. doi: 10.1016/j.immuni.2017.09.007.

PMID:
29045889
24.

The Critical Role of Biomedical Research in Pandemic Preparedness.

Marston HD, Paules CI, Fauci AS.

JAMA. 2017 Nov 14;318(18):1757-1758. doi: 10.1001/jama.2017.15033. No abstract available.

PMID:
28979970
25.

Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing.

Guzzo C, Ichikawa D, Park C, Phillips D, Liu Q, Zhang P, Kwon A, Miao H, Lu J, Rehm C, Arthos J, Cicala C, Cohen MS, Fauci AS, Kehrl JH, Lusso P.

Sci Immunol. 2017 May 12;2(11). pii: eaam7341. doi: 10.1126/sciimmunol.aam7341.

26.

Early antibody therapy can induce long-lasting immunity to SHIV.

Nishimura Y, Gautam R, Chun TW, Sadjadpour R, Foulds KE, Shingai M, Klein F, Gazumyan A, Golijanin J, Donaldson M, Donau OK, Plishka RJ, Buckler-White A, Seaman MS, Lifson JD, Koup RA, Fauci AS, Nussenzweig MC, Martin MA.

Nature. 2017 Mar 23;543(7646):559-563. doi: 10.1038/nature21435. Epub 2017 Mar 13.

27.

Yellow Fever - Once Again on the Radar Screen in the Americas.

Paules CI, Fauci AS.

N Engl J Med. 2017 Apr 13;376(15):1397-1399. doi: 10.1056/NEJMp1702172. Epub 2017 Mar 8. No abstract available.

28.

B-cell responses to HIV infection.

Moir S, Fauci AS.

Immunol Rev. 2017 Jan;275(1):33-48. doi: 10.1111/imr.12502. Review.

29.

Emerging and Reemerging Infectious Diseases: The Dichotomy Between Acute Outbreaks and Chronic Endemicity.

Paules CI, Fauci AS.

JAMA. 2017 Feb 21;317(7):691-692. doi: 10.1001/jama.2016.21079. No abstract available.

PMID:
28097318
30.

Association Between Human Immunodeficiency Virus Infection and Cardiovascular Diseases: Finding a Solution to Double Jeopardy.

Hadigan C, Paules CI, Fauci AS.

JAMA Cardiol. 2017 Feb 1;2(2):123-124. doi: 10.1001/jamacardio.2016.5177. No abstract available.

PMID:
28002559
31.

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.

Bar KJ, Sneller MC, Harrison LJ, Justement JS, Overton ET, Petrone ME, Salantes DB, Seamon CA, Scheinfeld B, Kwan RW, Learn GH, Proschan MA, Kreider EF, Blazkova J, Bardsley M, Refsland EW, Messer M, Clarridge KE, Tustin NB, Madden PJ, Oden K, O'Dell SJ, Jarocki B, Shiakolas AR, Tressler RL, Doria-Rose NA, Bailer RT, Ledgerwood JE, Capparelli EV, Lynch RM, Graham BS, Moir S, Koup RA, Mascola JR, Hoxie JA, Fauci AS, Tebas P, Chun TW.

N Engl J Med. 2016 Nov 24;375(21):2037-2050. Epub 2016 Nov 9.

32.

Meeting the Challenge of Epidemic Chikungunya.

Morens DM, Fauci AS.

J Infect Dis. 2016 Dec 15;214(suppl 5):S434-S435. No abstract available.

33.

Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy.

Byrareddy SN, Arthos J, Cicala C, Villinger F, Ortiz KT, Little D, Sidell N, Kane MA, Yu J, Jones JW, Santangelo PJ, Zurla C, McKinnon LR, Arnold KB, Woody CE, Walter L, Roos C, Noll A, Van Ryk D, Jelicic K, Cimbro R, Gumber S, Reid MD, Adsay V, Amancha PK, Mayne AE, Parslow TG, Fauci AS, Ansari AA.

Science. 2016 Oct 14;354(6309):197-202.

34.

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.

PREVAIL II Writing Group; Multi-National PREVAIL II Study Team, Davey RT Jr, Dodd L, Proschan MA, Neaton J, Neuhaus Nordwall J, Koopmeiners JS, Beigel J, Tierney J, Lane HC, Fauci AS, Massaquoi MBF, Sahr F, Malvy D.

N Engl J Med. 2016 Oct 13;375(15):1448-1456.

35.

Considerations for Developing a Zika Virus Vaccine.

Marston HD, Lurie N, Borio LL, Fauci AS.

N Engl J Med. 2016 Sep 29;375(13):1209-12. doi: 10.1056/NEJMp1607762. No abstract available.

36.

Antimicrobial Resistance.

Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS.

JAMA. 2016 Sep 20;316(11):1193-1204. doi: 10.1001/jama.2016.11764.

PMID:
27654605
37.

The Role of the Virtuous Investigator in Protecting Human Research Subjects.

Grady C, Fauci AS.

Perspect Biol Med. 2016;59(1):122-31. doi: 10.1353/pbm.2016.0021.

PMID:
27499489
38.

Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy.

Imamichi H, Dewar RL, Adelsberger JW, Rehm CA, O'Doherty U, Paxinos EE, Fauci AS, Lane HC.

Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):8783-8. doi: 10.1073/pnas.1609057113. Epub 2016 Jul 18.

39.

The Acquired Immune Deficiency Syndrome: The Ever-Broadening Clinical Spectrum.

Fauci AS.

JAMA. 2016 Jul 12;316(2):230. doi: 10.1001/jama.2015.17093. No abstract available.

PMID:
27404204
40.

An HIV Vaccine: Mapping Uncharted Territory.

Fauci AS.

JAMA. 2016 Jul 12;316(2):143-4. doi: 10.1001/jama.2016.7538. No abstract available.

PMID:
27404178
41.

Maturational characteristics of HIV-specific antibodies in viremic individuals.

Meffre E, Louie A, Bannock J, Kim LJ, Ho J, Frear CC, Kardava L, Wang W, Buckner CM, Wang Y, Fankuchen OR, Gittens KR, Chun TW, Li Y, Fauci AS, Moir S.

JCI Insight. 2016;1(3). pii: e84610. Epub 2016 Mar 17.

42.

Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral Burdens.

Buckner CM, Kardava L, Zhang X, Gittens K, Justement JS, Kovacs C, McDermott AB, Li Y, Sajadi MM, Chun TW, Fauci AS, Moir S.

J Infect Dis. 2016 Aug 1;214(3):390-8. doi: 10.1093/infdis/jiw163. Epub 2016 Apr 27.

43.

Severe Meningoencephalitis in a Case of Ebola Virus Disease: A Case Report.

Chertow DS, Nath A, Suffredini AF, Danner RL, Reich DS, Bishop RJ, Childs RW, Arai AE, Palmore TN, Lane HC, Fauci AS, Davey RT.

Ann Intern Med. 2016 Aug 16;165(4):301-4. doi: 10.7326/M15-3066. Epub 2016 Apr 5. No abstract available.

44.

Basic science: Bedrock of progress.

Collins FS, Anderson JM, Austin CP, Battey JF, Birnbaum LS, Briggs JP, Clayton JA, Cuthbert B, Eisinger RW, Fauci AS, Gallin JI, Gibbons GH, Glass RI, Gottesman MM, Gray PA, Green ED, Greider FB, Hodes R, Hudson KL, Humphreys B, Katz SI, Koob GF, Koroshetz WJ, Lauer MS, Lorsch JR, Lowy DR, McGowan JJ, Murray DM, Nakamura R, Norris A, Perez-Stable EJ, Pettigrew RI, Riley WT, Rodgers GP, Sieving PA, Somerman MJ, Spong CY, Tabak LA, Volkow ND, Wilder EL.

Science. 2016 Mar 25;351(6280):1405. doi: 10.1126/science.351.6280.1405-a. No abstract available.

45.

Conducting clinical trials in outbreak settings: Points to consider.

Lane HC, Marston HD, Fauci AS.

Clin Trials. 2016 Feb;13(1):92-5. doi: 10.1177/1740774515618198. Epub 2016 Jan 14. No abstract available.

46.

Zika Virus in the Americas--Yet Another Arbovirus Threat.

Fauci AS, Morens DM.

N Engl J Med. 2016 Feb 18;374(7):601-4. doi: 10.1056/NEJMp1600297. Epub 2016 Jan 13. No abstract available.

47.

Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection.

Lynch RM, Boritz E, Coates EE, DeZure A, Madden P, Costner P, Enama ME, Plummer S, Holman L, Hendel CS, Gordon I, Casazza J, Conan-Cibotti M, Migueles SA, Tressler R, Bailer RT, McDermott A, Narpala S, O'Dell S, Wolf G, Lifson JD, Freemire BA, Gorelick RJ, Pandey JP, Mohan S, Chomont N, Fromentin R, Chun TW, Fauci AS, Schwartz RM, Koup RA, Douek DC, Hu Z, Capparelli E, Graham BS, Mascola JR, Ledgerwood JE; VRC 601 Study Team.

Sci Transl Med. 2015 Dec 23;7(319):319ra206. doi: 10.1126/scitranslmed.aad5752.

PMID:
26702094
48.

C. EVERETT KOOP, 14 OCTOBER 1916 - 25 FEBRUARY 2013.

Fauci AS.

Proc Am Philos Soc. 2014 Dec;158(4):455-60. No abstract available.

PMID:
26665591
49.

Ending the HIV-AIDS Pandemic--Follow the Science.

Fauci AS, Marston HD.

N Engl J Med. 2015 Dec 3;373(23):2197-9. doi: 10.1056/NEJMp1502020. Epub 2015 Dec 1. No abstract available.

50.

Immune correlates of vaccine protection against HIV-1 acquisition.

Corey L, Gilbert PB, Tomaras GD, Haynes BF, Pantaleo G, Fauci AS.

Sci Transl Med. 2015 Oct 21;7(310):310rv7. doi: 10.1126/scitranslmed.aac7732. Review.

Supplemental Content

Loading ...
Support Center